S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: Japan's Nikkei tops 40,000, as investors await China political meeting
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

$0.38
-0.01 (-2.86%)
(As of 03/1/2024 08:52 PM ET)
Today's Range
$0.38
$0.40
50-Day Range
$0.36
$0.58
52-Week Range
$0.35
$2.75
Volume
16,600 shs
Average Volume
181,119 shs
Market Capitalization
$6.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Shuttle Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Shuttle Pharmaceuticals in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1,912 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.69 out of 5 stars


SHPH stock logo

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.

SHPH Stock Price History

SHPH Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Shuttle Pharmaceuticals reports Q3 results
Shuttle Pharmaceuticals (NASDAQ: SHPH)
See More Headlines
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/03/2024
Next Earnings (Estimated)
3/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SHPH
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-3,030,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.56 per share

Miscellaneous

Free Float
9,503,000
Market Cap
$6.08 million
Optionable
Not Optionable
Beta
-1.18
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Anatoly Dritschilo M.D. (Age 80)
    Co-Founder, MD, CEO & Chairman of the Board
    Comp: $91.42k
  • Mr. Peter Dale Dritschilo M.B.A. (Age 55)
    M.D., President & COO
    Comp: $94.29k
  • Mr. Michael P. Vander Hoek (Age 64)
    CFO and VP of Operations & Regulatory
    Comp: $79.48k
  • Dr. Tyvin A. Rich M.D. (Age 76)
    Chief Medical Officer
    Comp: $65.06k
  • Dr. Milton Brown CSC (Age 59)
    M.D., Ph.D., Co-Founder & Director
  • Dr. Mira Jung Ph.D. (Age 75)
    Co-Founder & Chief Scientific Officer for Biology
  • Mr. Gene Jung Esq.
    General Counsel














SHPH Stock Analysis - Frequently Asked Questions

How have SHPH shares performed in 2024?

Shuttle Pharmaceuticals' stock was trading at $0.4550 at the beginning of 2024. Since then, SHPH stock has decreased by 16.4% and is now trading at $0.3803.
View the best growth stocks for 2024 here
.

Are investors shorting Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals saw a decrease in short interest in the month of February. As of February 15th, there was short interest totaling 87,700 shares, a decrease of 35.3% from the January 31st total of 135,500 shares. Based on an average daily trading volume, of 157,500 shares, the short-interest ratio is presently 0.6 days. Approximately 1.0% of the shares of the stock are sold short.
View Shuttle Pharmaceuticals' Short Interest
.

When is Shuttle Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024.
View our SHPH earnings forecast
.

When did Shuttle Pharmaceuticals IPO?

(SHPH) raised $10 million in an initial public offering (IPO) on Wednesday, August 31st 2022. The company issued 1,225,888 shares at $8.13 per share.

How do I buy shares of Shuttle Pharmaceuticals?

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SHPH) was last updated on 3/4/2024 by MarketBeat.com Staff